跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BILASTINA VISO FARMACÉUTICA 20 MG COMPRIMIDOS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
BILASTINA VISO FARMACÉUTICA 20 MG COMPRIMIDOS EFG
Approved
STANDARD
BILASTINA VISO FARMACÉUTICA 20 MG COMPRIMIDOS EFG
Glenmark Arzneimittel Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 21, 2024
Approval ID
32e9e5dabb086ebd
Company
Glenmark Arzneimittel Gmbh
Type
Standard
Approval Details
Approval Id
32e9e5dabb086ebd
Drug Cima Aemps Name
BILASTINA VISO FARMACÉUTICA 20 MG COMPRIMIDOS EFG
Register Number
89128
Holder Company Name
Glenmark Arzneimittel Gmbh
Marketing Company Name
Glenmark Farmaceutica S.L.U
Holder Company Detail Path
/organization/glenmark-arzneimittel-gmbh
Authorization Date
2024-02-21
Dosage Form
COMPRIMIDO
Dose
20 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Glenmark Arzneimittel Gmbh
Company Detail Path
/organization/glenmark-arzneimittel-gmbh
Company Information
Pharmaceutical Company Name
Glenmark Arzneimittel GmbH
Country Name
Germany
Website
http://www.glenmark.de
Active Ingredients
BILASTINA
20 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 21, 2024
Approval ID
32e9e5dabb086ebd
Type
Standard
Back to CIMA-AEMPS Approvals
